GBIO
Price
$0.42
Change
-$0.03 (-6.67%)
Updated
Apr 24 closing price
Capitalization
28.19M
6 days until earnings call
GLSI
Price
$10.44
Change
+$0.59 (+5.99%)
Updated
Apr 24 closing price
Capitalization
138.58M
24 days until earnings call
Ad is loading...

GBIO vs GLSI

Header iconGBIO vs GLSI Comparison
Open Charts GBIO vs GLSIBanner chart's image
Generation Bio
Price$0.42
Change-$0.03 (-6.67%)
Volume$408.53K
Capitalization28.19M
Greenwich LifeSciences
Price$10.44
Change+$0.59 (+5.99%)
Volume$89.89K
Capitalization138.58M
GBIO vs GLSI Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. GLSI commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and GLSI is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (GBIO: $0.42 vs. GLSI: $10.44)
Brand notoriety: GBIO and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 82% vs. GLSI: 106%
Market capitalization -- GBIO: $28.19M vs. GLSI: $138.58M
GBIO [@Biotechnology] is valued at $28.19M. GLSI’s [@Biotechnology] market capitalization is $138.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both GBIO and GLSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 4 bearish.
  • GLSI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GBIO and GLSI are a good buy in the short-term.

Price Growth

GBIO (@Biotechnology) experienced а +7.27% price change this week, while GLSI (@Biotechnology) price change was +16.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($139M) has a higher market cap than GBIO($28.2M). GLSI YTD gains are higher at: -7.035 vs. GBIO (-60.321). GLSI has higher annual earnings (EBITDA): -10.76M vs. GBIO (-74.26M). GBIO has more cash in the bank: 185M vs. GLSI (5.82M). GBIO has higher revenues than GLSI: GBIO (19.9M) vs GLSI (0).
GBIOGLSIGBIO / GLSI
Capitalization28.2M139M20%
EBITDA-74.26M-10.76M690%
Gain YTD-60.321-7.035857%
P/E RatioN/AN/A-
Revenue19.9M0-
Total Cash185M5.82M3,178%
Total Debt93.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
GBIOGLSI
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPAX8.39N/A
N/A
Invesco SteelPath MLP Alpha A
AEGSX33.15N/A
N/A
Invesco EQV European Equity R6
NCIGX28.64N/A
N/A
Nuveen International Value C
OPOCX83.18N/A
N/A
Invesco Discovery A
GQSCX12.00N/A
N/A
Glenmede Disciplined US Small Cap Eq Ptf

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ATOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-6.62%
ATOS - GBIO
50%
Loosely correlated
-0.73%
ABOS - GBIO
48%
Loosely correlated
+7.84%
AURA - GBIO
47%
Loosely correlated
-4.17%
ATNM - GBIO
45%
Loosely correlated
-2.31%
CCCC - GBIO
45%
Loosely correlated
N/A
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+5.99%
ABOS - GLSI
40%
Loosely correlated
+7.84%
GBIO - GLSI
40%
Loosely correlated
-6.62%
NAUT - GLSI
39%
Loosely correlated
-3.92%
DNLI - GLSI
38%
Loosely correlated
+4.17%
CLDX - GLSI
37%
Loosely correlated
+0.77%
More